Assignment of Rights to Financial Information. The rights granted pursuant to Section 7.1 may not be assigned or otherwise conveyed by the Purchaser or by any subsequent transferee of any such rights without the prior written consent of the Company; provided, however, that the Purchaser may assign such rights to a parent, subsidiary or affiliate of the Purchaser upon notice to the Company thereof.
Assignment of Rights to Financial Information. The rights granted pursuant to Sections 4.1 and 4.2 may be assigned by a Major Investor to a third party who acquires (in compliance with Section 2.3) at least 2,700,000 shares (appropriately adjusted for stock splits, stock dividends and the like) of Series D Preferred Stock and/or Series E Preferred Stock, from a Major Investor and who is not a competitor, or affiliated in any manner with a competitor, of the Company, provided that the Company receives notice at least twenty (20) days prior to such assignment.
Assignment of Rights to Financial Information. The rights granted pursuant to Section 2.1 and Section 2.3 may be assigned by the Stockholders (or by any permitted transferee of any such rights) so long as (i) the Company is given notice of any such assignment within a reasonable time after the date the same is effected, (ii) the transferee shall have acquired Registrable Securities (including shares of Designated Preferred prior to conversion into Registrable Securities) in a private transaction, and (iii) the transferee is not engaged in a business that is competitive with the Company.
Assignment of Rights to Financial Information. The rights granted pursuant to Section 7.1 may not be assigned or otherwise conveyed by any Purchaser or by any subsequent transferee of any such rights without the prior written consent of the Company; provided, however, that any Purchaser may assign to any transferee, other than a competitor of the Company, and after giving notice to the Company, the rights granted pursuant to Section 7.1 to (i) a transferee who acquires at least 66,700 shares of Preferred Stock and/or Common Stock issued upon conversion of the Preferred Stock (appropriately adjusted for recapitalizations) or (ii) any constituent partner of a Purchaser.
Assignment of Rights to Financial Information. The rights granted pursuant to Section 2.1 may be assigned by the Shareholders (or by any permitted transferee of any such rights) so long as (i) the Company is given notice of any such assignment within a reasonable time after the date the same is effected, (ii) the transferee shall have acquired (or, together with such transferee's Affiliates, after the acquisition shall then beneficially own) at least 250,000 shares of Registrable Securities (including shares Series A Preferred and Series B Preferred prior to conversion into Registrable Securities) in a private transaction and (iii) the transferee is not engaged in a business that is competitive with the Company.
Assignment of Rights to Financial Information. Subject to the limitations set forth in Section 4.1 the rights granted pursuant to Section 4.1 may be assigned or otherwise conveyed by the Investors or by any subsequent transferee to an investor who acquires a minimum of 100,000 shares of Preferred Stock, other than a competitor of the Company, as reasonably determined by the Board of Directors of the Company excluding any director with an interest in such transferee, provided that written notice of such assignment or conveyance is given to the Company.
Assignment of Rights to Financial Information. The rights to receive information pursuant to Sections 2.1 and 2.2 may be assigned or otherwise conveyed by any Major Purchaser or subsequent transferee of shares of Preferred Stock or Conversion Stock only to an affiliate or to a transferee who acquires at least 12,800 shares of Preferred Stock, Conversion Stock or a combination thereof (each, on an as-converted to common stock basis, as adjusted for recapitalizations, stock combinations, stock dividends, stock splits and the like); provided, however, that the transferee of such rights is not deemed by a majority of the Board, in its reasonable judgment and sole discretion, to be a direct competitor of the Company. Upon request of a Major Purchaser, the Board will promptly (in no event later than five (5) business days after such request) inform such Major Purchaser if it deems a potential assignee to be a competitor of the Company.
Assignment of Rights to Financial Information. The rights granted pursuant to Section 8.1 may not be assigned or conveyed by the Purchaser or by any subsequent transferee of such rights without the prior written consent of the Company; provided, however, that the Purchaser and any transferee, after giving notice to the Company, may assign such rights to any transferee that acquires no fewer than 2,200,000 shares of Common Stock (subject to adjustment for stock splits, combinations, reclassifications, and other similar events) (including for purposes of determining the number of shares of Common Stock, any shares of Common Stock issued or issuable upon conversion or exercise of other securities), other than a transferee that is a Competitor. For purposes of this Agreement, “Competitor” shall mean any party engaged, directly or indirectly, in drug development for therapies for spinal cord injuries or multiple sclerosis.”
Assignment of Rights to Financial Information. The rights and obligations pursuant to Sections 18.1 and 18.2 may be assigned or otherwise conveyed by any Major Holder, or by any subsequent transferee of any such rights to a transferee, other than to a competitor or customer of the Company, upon prior written notice to the Company, upon the transfer by such Major Holder of at least 800,000 shares of Registrable Securities; provided, however, that the Company shall not be obligated under Section 18.1 to provide to any transferee information which it deems in good faith to be a trade secret or similar confidential information.
Assignment of Rights to Financial Information. The rights granted pursuant to Section 7.1 may not be assigned or otherwise conveyed by any Purchaser or by any subsequent transferee of any such rights without the prior written consent of GENESIS.
